Company: VCYT
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001384101-25-000130
Chunk: 88

Company: VERACYTE, INC.
Filing Date: 2025-11-05
Form: 10-Q
Item: Part I, Item 8
Chunk 88
---
 stock option plans10,899,141 8,971,566 Common stock available for the Employee Stock Purchase Plan895,255 1,051,407 Total16,964,996 15,796,355 

8. Components of Other Income

Other income, net consists of the following (in thousands of dollars): Three Months Ended September 30,Nine Months Ended September 30, 2025202420252024Interest income$3,482 $2,898 $9,181 $8,293 Loss on deconsolidation of subsidiary(6,708)— (6,708)— Interest expense— (1)(1)(2)Gain (loss) on currency revaluation(832)1,487 4,062 756 Other1 447 451 1,287  Total$(4,057)$4,831 $6,985 $10,334 

9. Segment

The chief operating decision maker for the Company is the Chief Executive Officer, who reviews financial information presented on a consolidated basis for purposes of allocating resources and assessing financial performance.  The Company has a single reporting unit associated with the development and commercialization of diagnostic tests and biopharmaceutical services. The accounting policies of the Company's single segment are the same as those described in the summary of significant accounting policies in Note 1, Organization, Description of Business and Summary of Significant Accounting Policies. The chief operating decision maker assesses performance of the Company's single segment and decides how to allocate resources based on consolidated net income. Under the current organizational structure, this measure is not discreetly available or required individually for any of the Company’s business activities and is only available at the consolidated level. The monitoring of budgeted versus actual results are used in assessing performance of the Company's single segment, allocating resources and in establishing management’s compensation. The Company's chief operating decision maker intends for all revenue generating activities to rely on cross-functional activities across the consolidated entity in order to operate. No individual besides the chief operating decision maker has been tasked with reviewing discreet operating results of the business activities, nor is there any intent to bifurcate the overall business review process to produce discreet operating results specific to any of the Company's business activities. The measure of segment assets is reported on the consolidated balance sheet as total consolidated assets. Consolidated revenue does not include any inter-segment sales or transfers.

19

Information about reported segment revenue, measures of segment profit or loss, significant